Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents

SAR studies of 3-aryl-5-aryl-1,2,4-oxadiazoles and the identification of 4g and 4h as lead compounds are reported.